These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 12976346)

  • 1. A clinical evaluation of the treatment of hypertension with dihydrogenated ergotoxine alkaloids.
    SUTTON GC; BUCKINGHAM W; BROWN RD; SUTTON DC
    Am Heart J; 1952 Oct; 44(4):622-8. PubMed ID: 12976346
    [No Abstract]   [Full Text] [Related]  

  • 2. Dihydrogenated ergot alkaloids in the treatment of essential hypertension.
    DUPUY HJ; SIGNORELLI J; ATTYAH AM
    Circulation; 1952 Feb; 5(2):285-6. PubMed ID: 14896474
    [No Abstract]   [Full Text] [Related]  

  • 3. Dihydrogenated ergot alkaloids (hydergine) in the treatment of essential hypertension.
    BECHGAARD P; PAULSEN L
    Acta Med Scand; 1953; 145(3):189-99. PubMed ID: 13079630
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of dihydrogenated derivatives of ergotoxin in arterial hypertension].
    MERLEN JF
    Gaz Med Fr; 1952 Sep; 59(17):1011-22. PubMed ID: 13010442
    [No Abstract]   [Full Text] [Related]  

  • 5. Dihydrogenated alkaloids of ergot in the investigation and treatment of diastolic hypertension.
    GIBBS DF
    Br Heart J; 1952 Jan; 14(1):77-86. PubMed ID: 14904818
    [No Abstract]   [Full Text] [Related]  

  • 6. [Sympathicolytic and adrenolytic actions of some alkaloids of ergotoxine].
    MENDEZ L
    Arch Inst Cardiol Mex; 1951 Apr; 21(2):196-204. PubMed ID: 14858106
    [No Abstract]   [Full Text] [Related]  

  • 7. [Treatment of hypertension with dihydric alkaloids (hydergine)].
    GARAN R; ONEN KH
    Tip Fak Mecm; 1952; 15(2):740-7. PubMed ID: 13049347
    [No Abstract]   [Full Text] [Related]  

  • 8. The effect of the hydrogenated ergotoxine-group alkaloids on the intact human uterus.
    GARRETT WJ; EMBREY MP
    J Obstet Gynaecol Br Emp; 1955 Aug; 62(4):523-9. PubMed ID: 13252453
    [No Abstract]   [Full Text] [Related]  

  • 9. Observations on the action of the hydrogenated alkaloids of the ergotoxine group on the circulation in man.
    BARCROFT H; KONZETT H; SWAN HJ
    J Physiol; 1951 Feb; 112(3-4):273-91. PubMed ID: 14825212
    [No Abstract]   [Full Text] [Related]  

  • 10. On the chromatography of hydrogenated ergot alkaloids of the ergotoxine group.
    ADAMANIS F; PAWELCZYK E; PLOTKOWIAKOWA Z
    Bull Soc Amis Sci (Med) (Poznan); 1960; C-10():95-104. PubMed ID: 14448225
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical evaluation of combined hydrogenated ergot alkaloids (hydergine) in arterial hypertension with special reference to their action in central manifestations.
    TANDOWSKY RM
    Circulation; 1954 Jan; 9(1):48-56. PubMed ID: 13116375
    [No Abstract]   [Full Text] [Related]  

  • 12. [Certain hydrogenated ergot alkaloids in the therapy of hypertensive disease].
    DONZELOT E; KAUFMANN H; COZANET P; JEGOU L
    Sem Hop; 1952 Apr; 28(25):1058-62. PubMed ID: 14958421
    [No Abstract]   [Full Text] [Related]  

  • 13. [Treatment of arterial hypertension with dihydrogenated ergot alkaloids of Secale cornutum].
    GUANTIERI G; VITTONE A
    Riforma Med; 1954 May; 68(20):540-6. PubMed ID: 13186655
    [No Abstract]   [Full Text] [Related]  

  • 14. [The possibility for treatment of hypertension with dihydroalkaloids of ergot (hydergin)].
    APPELHANS M; KAISER K; WATERLOH E; WELTE E
    Dtsch Med Wochenschr; 1954 Oct; 79(40):1481-4. PubMed ID: 13220096
    [No Abstract]   [Full Text] [Related]  

  • 15. [The action of dihydrogenated ergot alkaloids in normal and hypertensive individuals].
    DURANTE U; FUSCO M
    Arch Sci Med (Torino); 1959 Jul; 108():53-92. PubMed ID: 13818806
    [No Abstract]   [Full Text] [Related]  

  • 16. The hydrogenated ergot alkaloids (hydergine); a hypotensive agent.
    SCHULTZ FB
    Am Pract Dig Treat; 1953 May; 4(5):330-6. PubMed ID: 13050917
    [No Abstract]   [Full Text] [Related]  

  • 17. The effect of hydrogenated ergot alkaloids on elevated blood pressure levels.
    LABECKI TD; BRIGHT IB; GABLE GP; HAMILTON HN
    Miss Doct; 1953 Aug; 31(3):80-4. PubMed ID: 13072180
    [No Abstract]   [Full Text] [Related]  

  • 18. Evaluation of a new adrenolytic in the treatment of hypertension.
    VON HUEBER EF
    Rev Med Cordoba; 1952 Sep; 40(9):267-72. PubMed ID: 13004489
    [No Abstract]   [Full Text] [Related]  

  • 19. [The use of hydergine and protoveratrine in therapy of hypertension].
    HUEBER EF; WOHLRAB K
    Wien Z Inn Med; 1953; 34(7-8):267-73. PubMed ID: 13103079
    [No Abstract]   [Full Text] [Related]  

  • 20. [Treatment of delusions of persecution, with high agitation, by dihydrogenated ergot alkaloids].
    PICARD P; NAVARRANNE P
    Ann Med Psychol (Paris); 1955 Jun; 113 2(1):77-9. PubMed ID: 13238943
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.